PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Aadi Bioscience, Inc. (AADI)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS00032Q1040
CUSIP00032Q104
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$53.53M
EPS-$2.44
Revenue (TTM)$24.35M
Gross Profit (TTM)-$18.78M
EBITDA (TTM)-$71.76M
Year Range$1.55 - $8.65
Target Price$11.67
Short %5.89%
Short Ratio4.39

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AADI

Aadi Bioscience, Inc.

Popular comparisons: AADI vs. CPRX

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Aadi Bioscience, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%OctoberNovemberDecember2024FebruaryMarch
-97.37%
112.14%
AADI (Aadi Bioscience, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Aadi Bioscience, Inc. had a return of 17.33% year-to-date (YTD) and -65.40% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date17.33%10.04%
1 month19.70%3.53%
6 months-54.60%22.79%
1 year-65.40%32.16%
5 years (annualized)-29.46%13.15%
10 years (annualized)N/A10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-8.91%7.07%
202318.20%-23.17%-9.50%20.09%-61.60%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Aadi Bioscience, Inc. (AADI) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
AADI
Aadi Bioscience, Inc.
-0.75
^GSPC
S&P 500
2.76

Sharpe Ratio

The current Aadi Bioscience, Inc. Sharpe ratio is -0.75. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-0.75
2.76
AADI (Aadi Bioscience, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Aadi Bioscience, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-97.61%
0
AADI (Aadi Bioscience, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Aadi Bioscience, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aadi Bioscience, Inc. was 98.39%, occurring on Jan 17, 2024. The portfolio has not yet recovered.

The current Aadi Bioscience, Inc. drawdown is 97.61%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.39%Oct 11, 20171542Jan 17, 2024
-7.69%Sep 25, 20174Sep 29, 20177Oct 10, 201711
-2.15%Sep 13, 20171Sep 13, 20171Sep 14, 20172
-1.65%Aug 31, 20171Aug 31, 20171Sep 1, 20172
-0.83%Aug 10, 20171Aug 10, 20172Aug 15, 20173

Volatility

Volatility Chart

The current Aadi Bioscience, Inc. volatility is 35.15%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%OctoberNovemberDecember2024FebruaryMarch
35.15%
2.82%
AADI (Aadi Bioscience, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aadi Bioscience, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items